Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Oberg

Showing results (181-190 of 257) with videos related to

Pageof 26
Sort By:
World Journal of Gastroenterology|March 2, 2018
Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancerMohamad A Mouchli, Lidia Ouk, Marianne R Scheitel, et al.
Breast Cancer Research and Treatment|July 24, 2015
Gene signature model for breast cancer risk prediction for women with sclerosing adenosisAmy C Degnim, Aziza Nassar, Melody Stallings-Mann, et al.
Gynecologic Oncology|January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancerT M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
International Journal of Molecular Epidemiology and Genetics|June 21, 2011
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcomePrema Peethambaram, Brooke L Fridley, Robert A Vierkant, et al.
International Journal of Cancer|November 23, 2024
Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanismsKatherine A English, Michelle Goldsworthy, Brittannie Willis, et al.
Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.
World Journal of Surgery|May 23, 2002
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patientsIan D Hay, Geoffrey B Thompson, Clive S Grant, et al.
Plos One|June 23, 2011
miRNA expression in colon polyps provides evidence for a multihit model of colon cancerAnn L Oberg, Amy J French, Aaron L Sarver, et al.
Gynecologic Oncology|January 27, 2015
Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo ClinicAndrea E Wahner Hendrickson, Kieran M Hawthorne, Ellen L Goode, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
Pageof 26

Showing results (181-190 of 257) with videos related to

Sort By:
Pageof 26
World Journal of Gastroenterology|March 2, 2018
Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancerMohamad A Mouchli, Lidia Ouk, Marianne R Scheitel, et al.
Breast Cancer Research and Treatment|July 24, 2015
Gene signature model for breast cancer risk prediction for women with sclerosing adenosisAmy C Degnim, Aziza Nassar, Melody Stallings-Mann, et al.
Gynecologic Oncology|January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancerT M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
International Journal of Molecular Epidemiology and Genetics|June 21, 2011
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcomePrema Peethambaram, Brooke L Fridley, Robert A Vierkant, et al.
International Journal of Cancer|November 23, 2024
Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanismsKatherine A English, Michelle Goldsworthy, Brittannie Willis, et al.
Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.
World Journal of Surgery|May 23, 2002
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patientsIan D Hay, Geoffrey B Thompson, Clive S Grant, et al.
Plos One|June 23, 2011
miRNA expression in colon polyps provides evidence for a multihit model of colon cancerAnn L Oberg, Amy J French, Aaron L Sarver, et al.
Gynecologic Oncology|January 27, 2015
Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo ClinicAndrea E Wahner Hendrickson, Kieran M Hawthorne, Ellen L Goode, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
Pageof 26